Chambers AF - Search Results

1

p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. van Meyel DJ, et al. Among authors: chambers af. J Natl Cancer Inst. 1994 Jul 6;86(13):1011-7. doi: 10.1093/jnci/86.13.1011. J Natl Cancer Inst. 1994. PMID: 8007011

2

p53 and ras gene expression in human esophageal cancer and Barrett's epithelium: a prospective study.

Sorsdahl K, Casson AG, Troster M, Van Meyel D, Inculet R, Chambers AF. Sorsdahl K, et al. Among authors: chambers af. Cancer Detect Prev. 1994;18(3):179-85. Cancer Detect Prev. 1994. PMID: 8076380

3

Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma.

van Meyel DJ, Ramsay DA, Chambers AF, Macdonald DR, Cairncross JG. van Meyel DJ, et al. Among authors: chambers af. Ann Neurol. 1994 Jan;35(1):120-2. doi: 10.1002/ana.410350120. Ann Neurol. 1994. PMID: 8285583

4

Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absence of a p53-dependent cell cycle arrest [corrected].

Nutt CL, Chambers AF, Cairncross JG. Nutt CL, et al. Among authors: chambers af. Cancer Res. 1996 Jun 15;56(12):2748-51. Cancer Res. 1996. PMID: 8665508

5

Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy.

Nutt CL, Noble M, Chambers AF, Cairncross JG. Nutt CL, et al. Among authors: chambers af. Cancer Res. 2000 Sep 1;60(17):4812-8. Cancer Res. 2000. PMID: 10987291

6

Osteopontin expression in lung cancer.

Chambers AF, Wilson SM, Kerkvliet N, O'Malley FP, Harris JF, Casson AG. Chambers AF, et al. Lung Cancer. 1996 Nov;15(3):311-23. doi: 10.1016/0169-5002(95)00595-1. Lung Cancer. 1996. PMID: 8959677

7

ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer.

Casson AG, Wilson SM, McCart JA, O'Malley FP, Ozcelik H, Tsao MS, Chambers AF. Casson AG, et al. Among authors: chambers af. Int J Cancer. 1997 Sep 4;72(5):739-45. doi: 10.1002/(sici)1097-0215(19970904)72:5<739::aid-ijc6>3.0.co;2-t. Int J Cancer. 1997. PMID: 9311587

8

Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient mice.

van Meyel DJ, Sanchez-Sweatman OH, Kerkvliet N, Stitt L, Ramsay DA, Khokha R, Chambers AF, Cairncross JG. van Meyel DJ, et al. Among authors: chambers af. Int J Oncol. 1998 Nov;13(5):917-22. doi: 10.3892/ijo.13.5.917. Int J Oncol. 1998. PMID: 9772279

9

Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression.

Chambers AF, Denhardt GH, Wilson SM, Cairncross JG. Chambers AF, et al. J Neurooncol. 1991 Aug;11(1):43-8. doi: 10.1007/BF00166996. J Neurooncol. 1991. PMID: 1919645

10

O6-methylguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage.

Nutt CL, Costello JF, Bambrick LL, Yarosh DB, Swinnen LJ, Chambers AF, Cairncross JG. Nutt CL, et al. Among authors: chambers af. Can J Neurol Sci. 1995 May;22(2):111-5. doi: 10.1017/s0317167100040178. Can J Neurol Sci. 1995. PMID: 7627911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters